| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/06/1992 | WO1992004441A1 Production of human lysozyme in methylotrophic yeast cells and efficient secretion therefrom |
| 03/06/1992 | CA2089752A1 Production of human lysozyme in methylotrophic yeast cells and efficient secretion therefrom |
| 03/06/1992 | CA2049129A1 Haemophilus paragallinarum vaccine |
| 03/05/1992 | WO1992003737A1 Sequential c-terminal degradation of peptides and proteins |
| 03/05/1992 | WO1992003733A1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 03/05/1992 | WO1992003579A1 An augmented western blot format and immunoassay for detection of viral antibodies |
| 03/05/1992 | WO1992003578A1 In vitro retroviral integration assay |
| 03/05/1992 | WO1992003569A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | WO1992003562A1 Dna, dna constructs, cells and plants derived therefrom |
| 03/05/1992 | WO1992003558A1 Interleukin-2-leukotoxin gene fusions and uses thereof |
| 03/05/1992 | WO1992003554A1 Infectious laryngotracheitis virus vaccine |
| 03/05/1992 | WO1992003553A1 Footrot vaccine |
| 03/05/1992 | WO1992003552A1 P. falciparum-infected red corpuscles and immunogenic compositions containing same |
| 03/05/1992 | WO1992003550A1 Ryegrass pollen allergen |
| 03/05/1992 | WO1992003549A1 Specific dna sequences of a nematode which can be used for the diagnosis of infection with the nematode |
| 03/05/1992 | WO1992003548A1 Human zona pellucida protein zp3 |
| 03/05/1992 | WO1992003547A1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEINS, gD, gI AND gE |
| 03/05/1992 | WO1992003546A1 Enhancement of production of native products in corynebacterium by expression of cloned bacterial hemoglobin |
| 03/05/1992 | WO1992003545A1 Flavivirus recombinant poxvirus vaccine |
| 03/05/1992 | WO1992003539A1 Virus resistance in plants |
| 03/05/1992 | WO1992003537A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | WO1992003535A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 03/05/1992 | WO1992003479A1 Replication initiator protein complex and methods of use thereof |
| 03/05/1992 | WO1992003477A1 Biologically active compound, a process for the preparation thereof and use of the same |
| 03/05/1992 | WO1992003475A1 Enterovirus peptides |
| 03/05/1992 | WO1992003474A1 METHOD OF INTERFERING WITH FORMATION OF α-ANTICHYMOTRYPSIN-β-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN |
| 03/05/1992 | WO1992003472A1 Peptides containing amino-polyols as transition-state mimics |
| 03/05/1992 | WO1992003468A1 Method for isolating alpha-lactalbumin from whey |
| 03/05/1992 | WO1992003467A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/05/1992 | WO1992003457A1 Entamoeba histolytica immunodominant surface antigens |
| 03/05/1992 | WO1992003456A1 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 03/05/1992 | WO1992003161A1 Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection |
| 03/05/1992 | WO1992003160A1 Papua new guinea human t-lymphotropic virus |
| 03/05/1992 | WO1992003156A1 Membrane-derived antiflea vaccines |
| 03/05/1992 | WO1992003153A1 Hemoglobin-oligomer based composition and method to make same |
| 03/05/1992 | WO1992003150A1 Cell density signal molecule isolated from embryonic tendon cells |
| 03/05/1992 | WO1992003149A1 Superior thrombomodulin analogs for pharmaceutical use |
| 03/05/1992 | WO1992003139A1 Oligonucleotide modulation of cell adhesion |
| 03/05/1992 | WO1991015516A3 Hepatitis c virus epitopes |
| 03/05/1992 | DE4027154A1 Mutation der hrv2 2a Mutation of HRV2 2a |
| 03/05/1992 | CA2648350A1 Superior thrombomodulin analogs for pharmaceutical use |
| 03/05/1992 | CA2090105A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | CA2089497A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | CA2087977A1 Plant fatty acid synthases |
| 03/05/1992 | CA2067241A1 Hemoglobin-oligomer based composition and method to make same |
| 03/05/1992 | CA2067150A1 Sequential c-terminal degradation of peptides and proteins |
| 03/05/1992 | CA2066160A1 Marek's disease herpesvirus dna segment encoding glycoproteins, gd, gi and ge |
| 03/05/1992 | CA2050434A1 Renin inhibitors |
| 03/04/1992 | EP0473564A1 Anticoagulant combination of laci and sulfated polysaccharides |
| 03/04/1992 | EP0473268A2 Continuous release pharmaceutical compositions comprising a polypeptide covalently conjugated to a water soluble polymer |
| 03/04/1992 | EP0473210A2 Recombinant Marek's disease virus |
| 03/04/1992 | EP0473145A1 Compositions for inhibiting aminoglycoside nephrotoxicity |
| 03/04/1992 | EP0473128A2 Monoclonal antibody specifically reactive with human perforin |
| 03/04/1992 | EP0473111A2 Recombinant mite allergen |
| 03/04/1992 | EP0473084A2 Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides |
| 03/04/1992 | EP0473080A2 Chondromodulin-I protein |
| 03/04/1992 | EP0472987A1 Antimicrobial peptides active against plant pathogens, their use and screening methods pertaining thereto |
| 03/04/1992 | EP0472725A1 Treatment of polycystic ovarian disease. |
| 03/04/1992 | EP0472712A1 Novel sequences preferentially expressed in early seed development and methods related thereto |
| 03/04/1992 | EP0472711A1 Process for preparing a concentrated solution of factor viii |
| 03/04/1992 | EP0472662A1 Antifreeze polypeptides |
| 03/04/1992 | EP0472659A1 T-lymphotropic retrovirus monoclonal antibodies |
| 03/04/1992 | EP0472658A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 03/04/1992 | EP0472599A1 Methods and systems for determining the presence of a pneumocystis carinii antigen in blood |
| 03/04/1992 | EP0472579A1 Ribosomal frameshift signals and uses |
| 03/04/1992 | EP0328542B1 Antiparathyroid antibody preparation |
| 03/04/1992 | CA2050425A1 Pharmaceutical composition and its mucous use |
| 03/03/1992 | US5093531 Polyethylene glycol substituted phenyl glyoxals |
| 03/03/1992 | US5093530 Intermediate for support for solid phase synthesis of peptides |
| 03/03/1992 | US5093479 Regulatory glycoprotein for immune response and the use, thereof in the production of t-cell growth factor |
| 03/03/1992 | US5093477 Testing for inhibitors of human immunodeficiency virus |
| 03/03/1992 | US5093475 Hindered linking agents derived from 2-iminothiolanes and methods |
| 03/03/1992 | US5093474 Process for the production of gelatin from fish skins |
| 03/03/1992 | US5093322 Tick-derived amblyommin and method of antithrombin therapy |
| 03/03/1992 | US5093317 Treating disorders by application of insulin-like growth factor |
| 03/03/1992 | US5093315 Aqueous solutions or solids |
| 03/03/1992 | US5093261 Monoclonal antibodies |
| 03/03/1992 | US5093258 For expressing immunogenic proteins, poultry vaccines |
| 03/03/1992 | US5093251 Cassette method of gene synthesis |
| 03/03/1992 | US5093242 Methods of generating desired amino-terminal residues in proteins |
| 03/03/1992 | US5093241 C-terminal cat fusion protein and process of preparation by recombinant dna |
| 03/03/1992 | US5093240 Variant aequorin genes and process for producing variant aequorin proteins |
| 03/03/1992 | US5093233 Antagonists with position 13 modification |
| 03/03/1992 | US5093198 Adjuvant-enhanced sustained release composition and method for making |
| 03/03/1992 | US5093120 Applying to plants and animals |
| 03/03/1992 | US5093119 Use of a Bacillus thuringiensis microbe for controlling lesser mealworm, Alphitobius diaperinus |
| 03/03/1992 | US5093118 Antigen of Blastomyces dermatitidis and its uses |
| 03/03/1992 | US5092885 Antitumor agents, wouond healing agents, promoters of cell adhesion to prostheses |
| 03/03/1992 | US5092876 Cell attachment peptides derived from amyloid P component |
| 03/03/1992 | CA1296669C Substance gif-2 and process for production of the same |
| 03/03/1992 | CA1296662C Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 03/03/1992 | CA1296661C Monoclonal antibodies specific for synthetic glycosphingolipids |
| 03/03/1992 | CA1296660C Monoclonal antibody against a ras oncogene p21 related dodecapeptide |
| 03/01/1992 | WO1992005760A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome |
| 03/01/1992 | WO1992004459A1 Macrophage activating factor from vitamin d binding protein |
| 03/01/1992 | WO1992004455A1 Multidomain hematopoiesis stimulators |
| 03/01/1992 | WO1992004377A1 HUMAN INTERFERON-η4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS |
| 03/01/1992 | WO1992004047A1 Methods of treating, diagnosing and monitoring therapies from levels of human oubain-like factor and antibody thereof |
| 03/01/1992 | WO1992004046A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 03/01/1992 | WO1992003555A1 Mutation of hrv2 2a |